132 related articles for article (PubMed ID: 25913523)
1. Auto-immune hypoparathyroidism.
Weetman AP
Ann Endocrinol (Paris); 2015 May; 76(2):89-91. PubMed ID: 25913523
[No Abstract] [Full Text] [Related]
2. Anti-parathyroid and anti-calcium sensing receptor antibodies in autoimmune hypoparathyroidism.
Brown EM
Endocrinol Metab Clin North Am; 2009 Jun; 38(2):437-45, x. PubMed ID: 19328421
[TBL] [Abstract][Full Text] [Related]
3. Immunosuppressive therapy of autoimmune hypoparathyroidism in a patient with activating autoantibodies against the calcium-sensing receptor.
Chamberlin M; Kemp EH; Weetman AP; Khadka B; Brown EM
Clin Endocrinol (Oxf); 2019 Jan; 90(1):214-221. PubMed ID: 30358904
[TBL] [Abstract][Full Text] [Related]
4. Functional autoantibodies cause hypoparathyroidism.
Husebye ES
J Clin Endocrinol Metab; 2009 Dec; 94(12):4655-7. PubMed ID: 19959750
[No Abstract] [Full Text] [Related]
5. Activating antibodies to the calcium-sensing receptor in two patients with autoimmune hypoparathyroidism.
Kifor O; McElduff A; LeBoff MS; Moore FD; Butters R; Gao P; Cantor TL; Kifor I; Brown EM
J Clin Endocrinol Metab; 2004 Feb; 89(2):548-56. PubMed ID: 14764760
[TBL] [Abstract][Full Text] [Related]
6. [Hypoparathyroidism associated with autoimmune disorder].
Yamauchi M; Sugimoto T
Clin Calcium; 2007 Aug; 17(8):1193-9. PubMed ID: 17660615
[TBL] [Abstract][Full Text] [Related]
7. Calcium-sensing receptor autoantibodies and idiopathic hypoparathyroidism.
Tomar N; Gupta N; Goswami R
J Clin Endocrinol Metab; 2013 Sep; 98(9):3884-91. PubMed ID: 23873991
[TBL] [Abstract][Full Text] [Related]
8. Calcium-sensing receptor autoantibody-mediated hypoparathyroidism associated with immune checkpoint inhibitor therapy: diagnosis and long-term follow-up.
Dadu R; Rodgers TE; Trinh VA; Kemp EH; Cubb TD; Patel S; Simon JM; Burton EM; Tawbi H
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581059
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of calcium sensing receptor autoantibodies in patients with sporadic idiopathic hypoparathyroidism.
Goswami R; Brown EM; Kochupillai N; Gupta N; Rani R; Kifor O; Chattopadhyay N
Eur J Endocrinol; 2004 Jan; 150(1):9-18. PubMed ID: 14713274
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and classification of autoimmune parathyroid disease.
Betterle C; Garelli S; Presotto F
Autoimmun Rev; 2014; 13(4-5):417-22. PubMed ID: 24424178
[TBL] [Abstract][Full Text] [Related]
11. Calcium-sensing receptor autoantibodies are relevant markers of acquired hypoparathyroidism.
Mayer A; Ploix C; Orgiazzi J; Desbos A; Moreira A; Vidal H; Monier JC; Bienvenu J; Fabien N
J Clin Endocrinol Metab; 2004 Sep; 89(9):4484-8. PubMed ID: 15356052
[TBL] [Abstract][Full Text] [Related]
12. Hypoparathyroidism and autoimmune polyendocrine syndromes.
Schott M; Scherbaum WA
N Engl J Med; 2004 Sep; 351(10):1032-3; author reply 1032-3. PubMed ID: 15342816
[No Abstract] [Full Text] [Related]
13. Activating Antibodies to The Calcium-sensing Receptor in Immunotherapy-induced Hypoparathyroidism.
Lupi I; Brancatella A; Cetani F; Latrofa F; Kemp EH; Marcocci C
J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 32112105
[TBL] [Abstract][Full Text] [Related]
14. Immune Checkpoint Inhibitor-Induced Hypoparathyroidism Associated With Calcium-Sensing Receptor-Activating Autoantibodies.
Piranavan P; Li Y; Brown E; Kemp EH; Trivedi N
J Clin Endocrinol Metab; 2019 Feb; 104(2):550-556. PubMed ID: 30252069
[TBL] [Abstract][Full Text] [Related]
15. Calcium-sensing receptor autoantibodies in primary hyperparathyroidism.
Charrié A; Chikh K; Peix JL; Berger N; Decaussin M; Veber S; Bienvenu J; Lifante JC; Fabien N
Clin Chim Acta; 2009 Aug; 406(1-2):94-7. PubMed ID: 19520070
[TBL] [Abstract][Full Text] [Related]
16. The calcium-sensing receptor is a target of autoantibodies in patients with autoimmune polyendocrine syndrome type 1.
Gavalas NG; Kemp EH; Krohn KJ; Brown EM; Watson PF; Weetman AP
J Clin Endocrinol Metab; 2007 Jun; 92(6):2107-14. PubMed ID: 17374709
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies against the calcium-sensing receptor and cytokines in autoimmune polyglandular syndromes types 2, 3 and 4.
Kemp EH; Kahaly GJ; Porter JA; Frommer L; Weetman AP
Clin Endocrinol (Oxf); 2018 Jan; 88(1):139-145. PubMed ID: 28941288
[TBL] [Abstract][Full Text] [Related]
18. [Chronic hypocalcemia due to anti-calcium sensing receptor antibodies].
Marques P; Santos R; Cavaco B; Leite V
Acta Med Port; 2014; 27(3):399-402. PubMed ID: 25017355
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies to the extracellular domain of the calcium sensing receptor in patients with acquired hypoparathyroidism.
Li Y; Song YH; Rais N; Connor E; Schatz D; Muir A; Maclaren N
J Clin Invest; 1996 Feb; 97(4):910-4. PubMed ID: 8613543
[TBL] [Abstract][Full Text] [Related]
20. Activating autoantibodies against the calcium-sensing receptor detected in two patients with autoimmune polyendocrine syndrome type 1.
Kemp EH; Gavalas NG; Krohn KJ; Brown EM; Watson PF; Weetman AP
J Clin Endocrinol Metab; 2009 Dec; 94(12):4749-56. PubMed ID: 19837919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
